Gynostemma pentaphyllum Extract Alleviates NASH in Mice: Exploration of Inflammation and Gut Microbiota

Feng-Yan Jiang,Si-Ran Yue,Yi-Yun Tan,Nan Tang,Yue-Song Xu,Bao-Jun Zhang,Yue-Jian Mao,Zheng-Sheng Xue,Ai-Ping Lu,Bao-Cheng Liu,Rui-Rui Wang

DOI: https://doi.org/10.3390/nu16111782

IF: 5.9

2024-06-06

Nutrients

Abstract:NASH (non-alcoholic steatohepatitis) is a severe liver disease characterized by hepatic chronic inflammation that can be associated with the gut microbiota. In this study, we explored the therapeutic effect of Gynostemma pentaphyllum extract (GPE), a Chinese herbal extract, on methionine- and choline-deficient (MCD) diet-induced NASH mice. Based on the peak area, the top ten compounds in GPE were hydroxylinolenic acid, rutin, hydroxylinoleic acid, vanillic acid, methyl vanillate, quercetin, pheophorbide A, protocatechuic acid, aurantiamide acetate, and iso-rhamnetin. We found that four weeks of GPE treatment alleviated hepatic confluent zone inflammation, hepatocyte lipid accumulation, and lipid peroxidation in the mouse model. According to the 16S rRNA gene V3–V4 region sequencing of the colonic contents, the gut microbiota structure of the mice was significantly changed after GPE supplementation. Especially, GPE enriched the abundance of potentially beneficial bacteria such as Akkerrmansia and decreased the abundance of opportunistic pathogens such as Klebsiella. Moreover, RNA sequencing revealed that the GPE group showed an anti-inflammatory liver characterized by the repression of the NF-kappa B signaling pathway compared with the MCD group. Ingenuity Pathway Analysis (IPA) also showed that GPE downregulated the pathogen-induced cytokine storm pathway, which was associated with inflammation. A high dose of GPE (HGPE) significantly downregulated the expression levels of the tumor necrosis factor-α (TNF-α), myeloid differentiation factor 88 (Myd88), cluster of differentiation 14 (CD14), and Toll-like receptor 4 (TLR4) genes, as verified by real-time quantitative PCR (RT-qPCR). Our results suggested that the therapeutic potential of GPE for NASH mice may be related to improvements in the intestinal microenvironment and a reduction in liver inflammation.

nutrition & dietetics

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve This paper aims to investigate the therapeutic effects of Gynostemma pentaphyllum extract (GPE) on methionine and choline-deficient (MCD) diet-induced non-alcoholic steatohepatitis (NASH) in mice, and to explore its potential mechanisms in alleviating liver inflammation and regulating gut microbiota. ### Background and Importance of the Problem Non-alcoholic fatty liver disease (NAFLD) includes two main subtypes: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). Among them, NASH is a more severe subtype characterized by hepatic lipid accumulation, inflammatory infiltration, and fibrosis. NASH can lead to hepatocellular carcinoma (HCC), and in patients with NASH cirrhosis, the annual incidence of HCC is estimated to be between 0.5% and 2.6%. Additionally, NASH is the second most common indication for liver transplantation in the United States after chronic hepatitis C. Although the FDA approved the first innovative drug for NASH in March 2024, prior to this, the management of NASH primarily focused on lifestyle interventions such as dietary changes and physical activity, as well as managing related comorbidities such as metabolic disorders and sarcopenia. ### Research Objectives 1. **Evaluate the anti-inflammatory effects of GPE**: Investigate the impact of GPE on liver pathological changes in MCD diet-induced NASH mice. 2. **Explore the effects of GPE on gut microbiota**: Analyze the regulatory effects of GPE on gut microbiota structure through 16S rRNA gene sequencing. 3. **Reveal the protective mechanisms of GPE**: Explore the specific mechanisms of GPE in improving liver inflammation and regulating the gut microenvironment through transcriptomic analysis. ### Main Findings 1. **GPE reduces liver inflammation and lipid accumulation**: Four weeks of GPE treatment significantly alleviated liver inflammation, hepatic lipid accumulation, and lipid peroxidation in NASH mice. 2. **GPE regulates gut microbiota**: After GPE supplementation, the structure of the gut microbiota in mice changed significantly, particularly increasing the abundance of beneficial bacteria such as Akkermansia and reducing the abundance of opportunistic pathogens such as Klebsiella. 3. **GPE inhibits inflammatory signaling pathways**: RNA sequencing showed that the livers of mice in the GPE group exhibited anti-inflammatory properties, with the NF-κB signaling pathway being inhibited. Additionally, high-dose GPE (HGPE) significantly downregulated the expression levels of TNF-α, Myd88, CD14, and TLR4 genes. ### Conclusion The study results indicate that GPE has potential therapeutic effects on MCD diet-induced NASH mice by improving the gut microenvironment and reducing liver inflammation. These findings provide a scientific basis for further development of GPE as a therapeutic drug for NASH.

Gynostemma pentaphyllum Extract Alleviates NASH in Mice: Exploration of Inflammation and Gut Microbiota

Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway

Ganoderic Acid A Ameliorates Non-Alcoholic Streatohepatitis (NASH) Induced by High-Fat High-Cholesterol Diet in Mice

Gynura Procumbens Aqueous Extract Alleviates Nonalcoholic Steatohepatitis Through CFLAR-JNK Pathway in Vivo and in Vitro

Gynostemma Pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with in Silico Assay

Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice

Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis

Epigallocatechin Gallate Protects Mice against Methionine–Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate Hepatic Injury and Regulate Metabolism

Chlorogenic Acid and Geniposide Combination Prevents NASH in Rats Fed High-fat Diet Via Microbiota and TLR4-LPS Pathway

Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice.

Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation

Gypenosides Improve the Intestinal Microbiota of Non-Alcoholic Fatty Liver in Mice and Alleviate Its Progression.

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism

Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing

Total glucosides of Picrorhizae Rhizome alleviate non-alcoholic steatohepatitis (NASH) by specifically targeting acyl-CoA oxidase 1

Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity

Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice

Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet

Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice

Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)